drugset / Trial / NCT01787032
Drug-drug Interaction Trial of BI 113608 in Combination With Ketoconazole and Voriconazole in Healthy Male Subjects
RandomizedCrossoverOpen-labelTreatment
Summary
The primary objective of this trial is to investigate the relative bioavailability of a single oral dose of BI 113608 without and with ketoconazole and voriconazole at steady state. The assessment of safety and tolerability of BI 113608 administered alone and upon co-administration will be an additional objective of this trial.
Timeline
- Start
- 2013-01
- Primary completion
- 2013-04
- Completion
- 2013-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BI 113608 | Unknown | — | Oral |
| Subject | Ketoconazole | Small molecule | — | Oral |
| Subject | Voriconazole | Small molecule | — | Oral |
Indications
No indication recorded.